
Cortibrook 6 MG Tablet
$0.43 / unit
Available Options
| Pack Size | Price | Price / Unit | Quantity | Action |
|---|---|---|---|---|
| 180 Tablets | $58.00 | $0.32/unit | ||
| 150 Tablets | $49.00 | $0.33/unit | ||
| 120 Tablets | $40.00 | $0.33/unit | ||
| 90 Tablets | $32.00 | $0.36/unit | ||
| 60 Tablets | $23.00 | $0.38/unit | ||
| 30 Tablets | $13.00 | $0.43/unit |
Product Description
What is this medicine?
CORTIBROOK 6 MG TABLET contains Deflazacort 6 mg and is marketed by Healing Pharma India Pvt. Ltd. It is a prescription corticosteroid (glucocorticoid) medicine. Current Indian product information confirms the composition as Deflazacort 6 mg and a pack of 10 tablets.
Deflazacort works by reducing inflammation and suppressing excessive immune-system activity. Cortibrook 6 mg is specifically listed for Duchenne muscular dystrophy (DMD), where corticosteroid treatment can help preserve muscle strength and slow progression of muscle weakness.
This medicine may be prescribed for:
Duchenne muscular dystrophy (DMD)
inflammatory conditions
certain autoimmune disorders
severe allergic and inflammatory conditions when corticosteroid therapy is appropriate
Cortibrook is a steroid medicine and should be taken only under medical supervision. Long-term corticosteroid treatment should not be stopped suddenly unless your healthcare provider specifically instructs you to do so.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
an unusual or allergic reaction to deflazacort or other corticosteroids
current or recurrent infection
tuberculosis or previous tuberculosis
recent exposure to chickenpox or measles
diabetes or a family history of diabetes
high blood pressure
heart disease or heart failure
stomach ulcer or other gastrointestinal disease
osteoporosis or weak bones
myasthenia gravis
glaucoma
cataracts
liver disease
kidney disease
thyroid problems
epilepsy or seizure disorder
depression, mood disorder, or other psychiatric illness
previous muscle problems caused by corticosteroids
recent surgery
plans to receive a vaccine
pregnant or trying to get pregnant
breast-feeding
Current Cortibrook information particularly advises caution in patients with tuberculosis, heart disease, stomach disorders, diabetes, osteoporosis, myasthenia gravis, psychiatric disorders, and kidney or liver dysfunction.
Tell your healthcare provider if you recently received a live vaccine or are scheduled to receive vaccinations.
Because corticosteroids suppress immune activity, they may make it more difficult for your body to fight infections.
How should I use this medicine?
Take CORTIBROOK 6 MG TABLET by mouth exactly as directed by your doctor or healthcare professional.
Swallow the tablet with a glass of water. Cortibrook can be taken with or without food. Current product guidance recommends taking it regularly, preferably at the same time each day when prescribed as a daily treatment.
Take your doses at regular intervals.
Do not take your medicine more often than directed.
Most importantly, do not suddenly stop taking Cortibrook after prolonged treatment. Long-term corticosteroid therapy may suppress the body's natural production of corticosteroid hormones, so your doctor may need to reduce the dose gradually.
The correct dose and duration depend on:
condition being treated
age and body weight
severity of disease
response to treatment
duration of therapy
other medicines being used
Overdosage: If you think you have taken too much of this medicine, contact your doctor or emergency medical service immediately.
NOTE: This medicine is only for you. Do not share this medicine with others.
What if I miss a dose?
If you miss a dose, take it as soon as you remember.
If it is almost time for your next dose, skip the missed dose and take only your regularly scheduled dose.
Do not:
take two doses together
double your next dose
take extra tablets to compensate for the missed dose
Current Cortibrook guidance likewise advises skipping a missed dose when the next scheduled dose is near rather than taking a double dose.
What may interact with this medicine?
Tell your healthcare provider if you take:
other corticosteroids
medicines that suppress the immune system
rifampicin
carbamazepine
phenytoin
phenobarbital
ketoconazole
certain antibiotics
medicines for diabetes
medicines for high blood pressure
diuretics or "water pills"
digoxin
anticoagulants or blood thinners
aspirin
NSAIDs such as ibuprofen or naproxen
vaccines
Vaccines
Tell your healthcare provider that you are taking deflazacort before receiving any vaccination.
Live vaccines may need to be avoided during significant corticosteroid/immunosuppressive treatment.
This list may not describe all possible interactions. Give your healthcare provider a list of all medicines, herbs, non-prescription drugs, vitamins, and dietary supplements you use.
Also tell them if you smoke or drink alcohol.
What should I watch for while using this medicine?
Visit your doctor or healthcare professional for regular checks on your progress, particularly if Cortibrook is being used for an extended period.
Your healthcare provider may monitor:
blood pressure
blood glucose
body weight
growth in children
bone health
eye health
signs of infection
electrolyte levels
Infection risk
Deflazacort suppresses immune activity and can increase susceptibility to infection.
Contact your healthcare provider if you develop:
fever
chills
persistent sore throat
persistent cough
painful urination
wounds that do not heal
unusual weakness
other signs of infection
Avoid unnecessary close contact with people who have contagious infections such as chickenpox or measles, particularly if you have never had these infections or have not been immunized.
Blood sugar
Corticosteroids may increase blood glucose. People with diabetes may require closer monitoring or changes to their diabetes treatment.
Bone health
Long-term corticosteroid treatment may contribute to osteoporosis and increased fracture risk.
Eye problems
Long-term corticosteroid treatment may increase the risk of:
cataracts
glaucoma
certain eye infections
Tell your healthcare provider if you develop blurred vision or other significant changes in eyesight.
Do not stop suddenly
If you have been taking Cortibrook regularly for a prolonged period, do not stop it suddenly unless instructed by your healthcare provider. Your dose may need to be gradually reduced.
What side effects may I notice from this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
fever or other signs of serious infection
severe weakness
difficulty breathing
swelling of the face, lips, tongue, or throat
severe allergic reaction
severe abdominal or stomach pain
black or bloody stools
unusual changes in mood or behavior
severe depression or confusion
significant vision changes
severe muscle weakness
unusual swelling
signs of very high blood sugar
Side effects that usually do not require immediate medical attention but should be reported if they continue or are bothersome:
increased appetite
weight gain
round or puffy face
indigestion
nausea
headache
dizziness
difficulty sleeping
mood changes
acne
increased sweating
fluid retention or swelling
Long-term or higher-dose corticosteroid treatment may also contribute to:
increased blood pressure
increased blood glucose
osteoporosis
muscle weakness
thinning of the skin
slower wound healing
increased susceptibility to infection
growth suppression in children
adrenal suppression
This list may not describe all possible side effects.
Where should I keep my medicine?
Keep CORTIBROOK 6 MG TABLETS out of the reach of children.
Current Indian product information identifies:
Brand Name: Cortibrook 6 mg Tablet
Generic Name: Deflazacort
Strength: 6 mg
Dosage Form: Tablet
Therapeutic Class: Corticosteroid / Glucocorticoid
Marketer: Healing Pharma India Pvt. Ltd.
Pack Size: 10 tablets per strip
Route: Oral
Primary Listed Use: Duchenne Muscular Dystrophy (DMD)
Country of Origin: India
Regulatory Status: Prescription medicine
Storage: Store below 30°C
Keep the tablets:
in their original blister or packaging
in a cool, dry place
below 30°C
protected from excessive heat
protected from moisture
away from direct sunlight
Do not use tablets that have changed significantly in colour, appearance, or physical condition.
Do not use Cortibrook 6 mg Tablets after the expiration date printed on the blister or outer packaging.




